60 related articles for article (PubMed ID: 9642450)
1. DNA quantification as a prognostic factor in gastric adenocarcinoma.
Azúa J; Romeo P; Morales M; Castiella T; Azúa J
Anal Quant Cytol Histol; 1998 Jun; 20(3):221-4. PubMed ID: 9642450
[TBL] [Abstract][Full Text] [Related]
2. DNA quantification as a prognostic factor in colorectal adenocarcinoma.
Azúa J; Romeo P; Morales M; Castiella T; Azúa J
Anal Quant Cytol Histol; 1999 Dec; 21(6):468-72. PubMed ID: 10626014
[TBL] [Abstract][Full Text] [Related]
3. DNA quantification as a prognostic factor in prostatic adenocarcinoma.
Azúa J; Romeo P; Valle J; Azúa J
Anal Quant Cytol Histol; 1996 Aug; 18(4):330-6. PubMed ID: 8862677
[TBL] [Abstract][Full Text] [Related]
4. Cytologic differentiation grade and malignancy DNA index in prostatic adenocarcinoma.
Azúa J; Romeo P; Valle J; Azúa J
Anal Quant Cytol Histol; 1997 Apr; 19(2):102-6. PubMed ID: 9113302
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value from DNA quantification by static cytometry in breast cancer.
Azúa J; Romeo P; Serrano M; Martinez Tello D; Azúa J
Anal Quant Cytol Histol; 1997 Feb; 19(1):80-6. PubMed ID: 9051190
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy: a prognostic factor of response to chemotherapy and survival in metastatic gastric adenocarcinoma.
Syrios J; Kechagias G; Agrogiannis G; Xynos ID; Kavantzas N; Lazaris AC; Amptoulach S; Mourati A; Sougioultzis S; Patsouris ES; Tsavaris N
Anticancer Res; 2013 Mar; 33(3):1209-14. PubMed ID: 23482804
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of DNA image cytometry in colorectal carcinoma.
Sampedro A; Urdiales G; Martínez-Nistal A; Riera J; Hardisson D
Anal Quant Cytol Histol; 1996 Jun; 18(3):214-20. PubMed ID: 8790835
[TBL] [Abstract][Full Text] [Related]
8. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
9. Comparison of DNA ploidy and S-phase fraction with prognostic factors in gastric cancer.
Setälä LP; Nordling S; Kosma VM; Lipponen PK; Eskelinen MJ; Hollmén SM; Syrjänen KJ; Alhava EM
Anal Quant Cytol Histol; 1997 Dec; 19(6):524-32. PubMed ID: 9893908
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
Lazăr D; Tăban S; Raica M; Sporea I; Cornianu M; Goldiş A; Vernic C
Rom J Morphol Embryol; 2008; 49(2):137-48. PubMed ID: 18516318
[TBL] [Abstract][Full Text] [Related]
11. [Significance of ploidy in prostatic cancer, quantified by a prospectively applicable procedure].
Valle Gerhold J; Azua Blanco J; Villarroya Rodríguez S; Romero Casabona P
Arch Esp Urol; 1996 Mar; 49(2):139-45. PubMed ID: 8702324
[TBL] [Abstract][Full Text] [Related]
12. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of nuclear DNA content in human gastric tumors. A static cytometry study in 87 cases].
Matturri L; Biondo B; Lavezzi AM
Minerva Chir; 1991 Jun; 46(12):653-60. PubMed ID: 1961588
[TBL] [Abstract][Full Text] [Related]
14. The importance of heterogeneity and of multiple site sampling in the prospective determination of deoxyribonucleic acid flow cytometry.
Stipa S; Danesi DT; Modini C; Cicconetti F; Mauro F; Schillaci A; Mecozzi A; Nicolanti V; Stipa F; Mancini M
Surg Gynecol Obstet; 1993 May; 176(5):427-34. PubMed ID: 8386859
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.
Zhang M; Wang J; Shi W; Chen W; Li W; Shu Y; Liu P; Lu K
Chin Med J (Engl); 2014; 127(10):1874-8. PubMed ID: 24824248
[TBL] [Abstract][Full Text] [Related]
16. Implications of flow cytometry in malignant conditions of the stomach.
Bronzo R; Heit P; Weissman G; Kahn E; McKinley M
Am J Gastroenterol; 1989 Sep; 84(9):1065-8. PubMed ID: 2773900
[TBL] [Abstract][Full Text] [Related]
17. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of DNA content in gastric and colorectal cancer.
Chistyakova OV; Zubrikhina GN
Anal Quant Cytol Histol; 1998 Feb; 20(1):52-8. PubMed ID: 9513691
[TBL] [Abstract][Full Text] [Related]
19. Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: results of EVOCAPE 2 multicentre prospective study.
Cotte E; Peyrat P; Piaton E; Chapuis F; Rivoire M; Glehen O; Arvieux C; Mabrut JY; Chipponi J; Gilly FN;
Eur J Surg Oncol; 2013 Jul; 39(7):707-14. PubMed ID: 23601984
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of image cytometry DNA parameters in tissue sections from breast and gastric cancers.
Haroske G; Kunze KD; Theissig F
Anal Cell Pathol; 1991 Jan; 3(1):11-24. PubMed ID: 1848088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
